DK1576959T3 - Softgel af NLKJ (neutrale lipider tilvejebragt fra kerner af jobstårer) til behandling af prostata sygdomme - Google Patents

Softgel af NLKJ (neutrale lipider tilvejebragt fra kerner af jobstårer) til behandling af prostata sygdomme

Info

Publication number
DK1576959T3
DK1576959T3 DK03753221.5T DK03753221T DK1576959T3 DK 1576959 T3 DK1576959 T3 DK 1576959T3 DK 03753221 T DK03753221 T DK 03753221T DK 1576959 T3 DK1576959 T3 DK 1576959T3
Authority
DK
Denmark
Prior art keywords
nlkj
treatment
cores
neutral lipids
soft gel
Prior art date
Application number
DK03753221.5T
Other languages
Danish (da)
English (en)
Inventor
Dapeng Li
Original Assignee
Dapeng Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dapeng Li filed Critical Dapeng Li
Application granted granted Critical
Publication of DK1576959T3 publication Critical patent/DK1576959T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03753221.5T 2002-09-28 2003-09-22 Softgel af NLKJ (neutrale lipider tilvejebragt fra kerner af jobstårer) til behandling af prostata sygdomme DK1576959T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA021373116A CN1485072A (zh) 2002-09-28 2002-09-28 治疗前列腺疾病的薏苡仁油软胶囊及其应用
PCT/CN2003/000803 WO2004028549A1 (en) 2002-09-28 2003-09-22 A coixenolide capsules for treating prostate disease

Publications (1)

Publication Number Publication Date
DK1576959T3 true DK1576959T3 (da) 2011-03-28

Family

ID=32034732

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03753221.5T DK1576959T3 (da) 2002-09-28 2003-09-22 Softgel af NLKJ (neutrale lipider tilvejebragt fra kerner af jobstårer) til behandling af prostata sygdomme

Country Status (11)

Country Link
US (1) US8299121B2 (https=)
EP (1) EP1576959B1 (https=)
JP (2) JP4718836B2 (https=)
CN (2) CN1485072A (https=)
AT (1) ATE493140T1 (https=)
AU (1) AU2003272841A1 (https=)
DE (1) DE60335575D1 (https=)
DK (1) DK1576959T3 (https=)
ES (1) ES2358420T3 (https=)
RU (1) RU2296581C2 (https=)
WO (1) WO2004028549A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492493B2 (en) * 2003-09-22 2016-11-15 Dapeng Li Softgel of NLKJ for treating prostate diseases
CA2573426C (en) 2004-07-30 2015-11-17 Exelixis, Inc. Pyrrole derivatives as pharmaceutical agents
CN102511824A (zh) * 2011-12-20 2012-06-27 金利油脂(苏州)有限公司 一种抗突变抗肿瘤的功能性食品
CN104173824B (zh) * 2014-07-18 2017-02-15 浙江康莱特集团有限公司 含有8种甘油三酯的薏苡仁油、制剂及其应用
CN105254498B (zh) * 2014-07-18 2017-11-21 浙江康莱特药业有限公司 化合物1,3‑二油酸‑2‑亚油酸甘油酯、制剂、制备方法及其应用
CN105311486A (zh) * 2014-07-18 2016-02-10 浙江康莱特集团有限公司 含有16种甘油酯的薏苡仁油、制剂及其应用
CN105250804A (zh) * 2014-07-18 2016-01-20 浙江康莱特集团有限公司 含有11种甘油三酯的薏苡仁油、制剂及其应用
US9884037B2 (en) * 2014-07-18 2018-02-06 Zhejiang Kanglaite Group Co., Ltd. Pharmaceutical composition containing 8 triglycerides, and preparations and use thereof
US9585929B2 (en) * 2014-07-18 2017-03-07 Zhejiang Kanglaite Group Co., Ltd. Coix seed oil containing 13 glycerides, and pharmaceutical preparation and use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5731604A (en) * 1980-07-31 1982-02-20 Okayasu Shoten:Kk Skin cosmetic
JPS58213719A (ja) * 1982-06-02 1983-12-12 Yasuo Araki 薬物的活性剤
JPS58210022A (ja) * 1982-06-02 1983-12-07 Yasuo Araki ハトムギ有効成分の純品精出法及び定量検定法
JPH01186815A (ja) * 1988-01-21 1989-07-26 Tokai Kapuseru Kk 軟カプセル剤およびその製造法
JPH02240019A (ja) * 1989-03-13 1990-09-25 Daicel Chem Ind Ltd 抗発癌プロモーター
JP2783848B2 (ja) * 1989-07-04 1998-08-06 晟 八木 新規ホスファチジルコリンカルシウムとその製法
CN1031261C (zh) * 1991-10-21 1996-03-13 中国科学院大连化学物理研究所 一种薏苡仁酯的提取方法
WO1993013660A1 (en) * 1992-01-06 1993-07-22 Health Maintenance Programs, Inc. Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
RU2123853C1 (ru) * 1992-09-16 1998-12-27 Пенг Ли Да Нейтральные липиды из зерен коикса nlkj, способ их получения, фармацевтическая композиция на их основе, нейтральные липиды для применения в качестве лекарственного средства
PH30249A (en) * 1992-09-16 1997-02-05 Zhejiang Provincial Hospital O Neutral lipids from endosperm of job's tears
CN1070680A (zh) * 1992-09-17 1993-04-07 李大鹏 薏苡仁中性油脂提取方法
CN1029662C (zh) 1992-09-17 1995-09-06 李大鹏 薏苡仁中性油脂及其提取方法
JPH06247858A (ja) * 1993-02-23 1994-09-06 Fujimoto Seiyaku Kk 慢性腎不全における抗骨異栄養症剤
JPH07115942A (ja) * 1993-08-09 1995-05-09 Sanji Kumai 生薬オリゴドリンク及び生薬オリゴゼリーの製造法
CN1064244C (zh) * 1993-11-09 2001-04-11 中国科学院大连化学物理研究所 中药薏苡仁提取物在制备治疗红班角化症、鳞状毛囊角化症、红皮症药物中的应用
US20010002269A1 (en) * 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
CN1075378C (zh) * 1997-09-30 2001-11-28 陈金义 一种抗肿瘤的中药乳剂及其制备方法
RU2178660C2 (ru) * 1998-07-31 2002-01-27 Закрытое акционерное общество "Эвалар" Лечебно-оздоровительная биологически активная добавка к пище "милона" и способ ее получения
ES2297934T3 (es) * 1998-08-03 2008-05-01 Ronald E. Wheeler Formula prostatica.
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
RU2174003C1 (ru) * 2000-04-17 2001-09-27 Зарубин Александр Андреевич Фармацевтическая лечебная композиция, способ лечебного и лечебно-профилактического ее применения
JP3983003B2 (ja) * 2001-03-15 2007-09-26 株式会社ファンケル グルタチオン増強用組成物
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
CN1440782A (zh) * 2003-03-28 2003-09-10 沈阳药科大学 一种含有薏苡仁油及鸦胆子油复合纳米乳剂的制备工艺及配方

Also Published As

Publication number Publication date
JP2006502193A (ja) 2006-01-19
CN1485072A (zh) 2004-03-31
AU2003272841A1 (en) 2004-04-19
EP1576959A4 (en) 2008-04-23
ES2358420T3 (es) 2011-05-10
EP1576959B1 (en) 2010-12-29
CN1684697A (zh) 2005-10-19
EP1576959A1 (en) 2005-09-21
US20100137427A9 (en) 2010-06-03
WO2004028549A1 (en) 2004-04-08
RU2005112775A (ru) 2006-11-10
DE60335575D1 (de) 2011-02-10
ATE493140T1 (de) 2011-01-15
CN1301128C (zh) 2007-02-21
JP4718836B2 (ja) 2011-07-06
RU2296581C2 (ru) 2007-04-10
HK1082426A1 (en) 2006-06-09
JP2011016852A (ja) 2011-01-27
US20050222249A1 (en) 2005-10-06
US8299121B2 (en) 2012-10-30

Similar Documents

Publication Publication Date Title
DK1576959T3 (da) Softgel af NLKJ (neutrale lipider tilvejebragt fra kerner af jobstårer) til behandling af prostata sygdomme
EP1391201A4 (en) MEDICAL COMPOSITIONS
DE60118004D1 (de) Substituierte pyrazole
BRPI0402760A (pt) Composição microbicida
TW200631597A (en) External use preparation and adhesive preparation thereof
ATE364378T1 (de) Beschichtungszusammensetzung zur geschmacksmaskierung
EE200300549A (et) Rasvhapete ravitoime võimendamine
DE60128215D1 (de) Beschichtungszusammensetzung zur geschmacksmaskierung
AR010270A1 (es) Composicion de cianoacrilato antimicrobiana, y un kit de partes que las contiene.
ECSP044862A (es) Pirenzepine ophthalmic gel
WO2003042246A3 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
DE60117602D1 (de) Transparente emulsion hohen ölgehalts mit dien-elastomeren
DE60036484D1 (en) Progressive additionslinsen
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
DE60031940D1 (de) Selbstbräunende zusammensetzungen , die dha und propolis-extrakt enthalten
PE20241347A1 (es) MODULAR LA EXPRESION DE APOLIPOPROTEINA (a)
ES2183982T3 (es) Productos para el tratamiento del cabello.
MY146794A (en) Use of an alpha-2-delta ligand for the treatment of luts
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
ATE445332T1 (de) Glutaminhaltige zusammensetzung gegen diarrhö
AU2003298850A1 (en) Quaternary ammonium esters for disinfection and preservation
Kim Consonantal and vocalic effects in Korean stop identification
EA201100575A1 (ru) Композиция дигидрата 3-(2,2,2-триметилгидразиниум)пропионата для наружного местного применения
SE0300535D0 (sv) Treatment of burns
AR046043A1 (es) Asociacion de un agente anti-aterotrombotico y un agente anti-agregacion de plaquetas y composiciones farmaceuticas que los contienen